Inst

Edward Jones Wins WealthManagement.com Industry Award for Thought Leadership

Retrieved on: 
Monday, September 27, 2021
Technology, Adoption, Thought leader, British Construction Industry Awards, Partnership, The Wealthy Barber, Inst, Health, Multimedia, Age wave, Method, CEO, Knowledge, Service, Family, Louis, COVID-19, Creativity, Retirement, View, Research, Four Pillars, Edward Jones, Organization, Investment, Industry, Financial adviser, Video game

ST. LOUIS, Sept. 27, 2021 /PRNewswire/ -- Financial services firm Edward Jones has received WealthManagement.com's 2021 Industry Award for Broker-Dealer Thought Leadership in recognition of its groundbreaking study, " The Four Pillars of the New Retirement ."

Key Points: 
  • ST. LOUIS, Sept. 27, 2021 /PRNewswire/ -- Financial services firm Edward Jones has received WealthManagement.com's 2021 Industry Award for Broker-Dealer Thought Leadership in recognition of its groundbreaking study, " The Four Pillars of the New Retirement ."
  • The WealthManagement.com Industry Awards (the "Wealthies") honors outstanding achievements by companies, organizations and individuals that support financial advisor success.
  • The Thought Leadership category specifically spotlights programs and content that propel the industry forward.
  • "At Edward Jones, we are dedicated to providing our financial advisors with the tools and insights they need to best serve their clients in planning for a secure retirement," said Ken Cella, principal, Edward Jones Client Strategies Group.

Edward Jones Debuts "Life's Moments" Ad Campaign

Retrieved on: 
Thursday, September 23, 2021
Retirement, View, Edward, Multimedia, Edward Jones, Life, Breakpoint, Partnership, Investment, Louis, Inst, We Got This, Omnicom Group, Financial adviser

"Life's Moments" illustrates how Edward Jones serves as a catalyst for supporting life in its biggest financial milestones and all the moments in between, underscoring the importance of overall financial wellbeing.

Key Points: 
  • "Life's Moments" illustrates how Edward Jones serves as a catalyst for supporting life in its biggest financial milestones and all the moments in between, underscoring the importance of overall financial wellbeing.
  • The campaign was created in partnership with Breakpoint, an Omnicom team that serves as Edward Jones' creative and advertising agency of record.
  • The campaign marks the first work from Breakpoint for Edward Jones.
  • Breakpoint also created a bespoke go-to-market media plan and buying strategy to bring the campaign to life with Edward Jones' key audiences of retail clients and investors across generations.

Stratasan and Ancore Health Announce Expansion of Outpatient Institutional Billing Data

Retrieved on: 
Tuesday, August 17, 2021
Data science, ASC, Founder, Growth, Strategic planning, Acquisition, Market, Physician, Efficiency, MRA, ROI, Marketing, Hospital, Intelligence, Inst, CEO, Practice management, Health, Health insurance

NASHVILLE, Tenn., Aug. 17, 2021 /PRNewswire-PRWeb/ -- Stratasan and Ancore Health are pleased to announce an expansion of the intelligence available in the Market Reimbursement Analyzer (MRA) tool with the addition of outpatient institutional billing.

Key Points: 
  • NASHVILLE, Tenn., Aug. 17, 2021 /PRNewswire-PRWeb/ -- Stratasan and Ancore Health are pleased to announce an expansion of the intelligence available in the Market Reimbursement Analyzer (MRA) tool with the addition of outpatient institutional billing.
  • With this update, two data modules are now available within the MRA tool: outpatient professional billing (MRA Outpatient: Prof) and outpatient institutional billing (MRA Outpatient: Inst), which is the newest enhancement.
  • This newly added institutional dataset provides reimbursement rates for outpatient hospitals and ASC institutional services.
  • Based in Franklin, TN, Ancore Health's team combines a cross-section of skill sets including financial operations, business intelligence, and data science.

Direct Biologics Announces FDA Acceptance of IND Application for a Phase I/II Clinical Trial Studying ExoFlo for Acute Respiratory Distress Syndrome

Retrieved on: 
Wednesday, July 14, 2021
Life sciences, Biotechnology, Health sciences, Food and Drug Administration, Biopharmaceutical, Pharmaceutical industry, Pharmacy, Investigational New Drug

Direct Biologics is the only EV company with INDs approved for the full breadth of COVID-19 indications, as well as ARDS.

Key Points: 
  • Direct Biologics is the only EV company with INDs approved for the full breadth of COVID-19 indications, as well as ARDS.
  • ExoFlo provides signaling proteins that have been shown to modulate inflammation and may stimulate bioactivity and direct cellular communication.
  • Direct Biologic's management team holds extensive collective experience in biologics research, development, and commercialization, making the Company a leader in the evolving, next-generation segment of the biotherapeutics industry.
  • Direct Biologics is dedicated to pursuing additional clinical applications of ExoFlo through the FDA's investigational new drug application process.For more information, visit www.directbiologics.com .